NEW YORK, NY / ACCESS Newswire / June 1, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading One River Digital sees spike in demand for carbon neutral Bitcoin.